Eli Lilly & Co. LLY
HEALTHCARE · DRUG MANUFACTURERS - GENERALi
Market dataready · fetched 2026-11-04T00:28:26.940Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-06
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-04T00:23:08.019030156Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-04T00:28:25.987339+00:00
Eli Lilly & Co. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 1455.90 | 40.7% | 3.7% | 1363.76 | 45.1% | 3.7% |
| 25Δ | 1445.90 | 39.6% | 3.1% | 1374.61 | 43.2% | 3.1% |
| 30Δ | 1438.31 | 40.0% | 2.7% | 1381.89 | 44.6% | 2.8% |
| 35Δ | 1431.94 | 41.4% | 2.4% | 1388.92 | 46.5% | 2.5% |
| 40Δ | 1424.82 | 41.3% | 2.1% | 1397.35 | 43.6% | 2.0% |
| 45Δ | 1417.89 | 40.6% | 1.8% | 1404.44 | 43.9% | 1.8% |
| 50Δ | 1411.28 | 40.2% | 1.5% | 1411.30 | 41.4% | 1.4% |
| 55Δ | 1405.29 | 36.5% | 1.2% | 1418.22 | 41.9% | 1.2% |
| 60Δ | 1398.10 | 41.2% | 1.1% | 1425.85 | 44.2% | 1.1% |
| 65Δ | 1392.14 | 39.1% | 0.9% | 1431.92 | 41.5% | 0.8% |
| 70Δ | 1385.00 | 39.5% | 0.7% | 1441.95 | 44.8% | 0.7% |
| 75Δ | 1378.68 | 38.2% | 0.6% | 1453.26 | 47.5% | 0.6% |
| 80Δ | 1369.49 | 39.4% | 0.4% | 1466.43 | 49.8% | 0.5% |
20Δ
- Pseudo strike
- 1455.90
- IV
- 40.7%
- B/E move
- 3.7%
- Pseudo strike
- 1363.76
- IV
- 45.1%
- B/E move
- 3.7%
25Δ
- Pseudo strike
- 1445.90
- IV
- 39.6%
- B/E move
- 3.1%
- Pseudo strike
- 1374.61
- IV
- 43.2%
- B/E move
- 3.1%
30Δ
- Pseudo strike
- 1438.31
- IV
- 40.0%
- B/E move
- 2.7%
- Pseudo strike
- 1381.89
- IV
- 44.6%
- B/E move
- 2.8%
35Δ
- Pseudo strike
- 1431.94
- IV
- 41.4%
- B/E move
- 2.4%
- Pseudo strike
- 1388.92
- IV
- 46.5%
- B/E move
- 2.5%
40Δ
- Pseudo strike
- 1424.82
- IV
- 41.3%
- B/E move
- 2.1%
- Pseudo strike
- 1397.35
- IV
- 43.6%
- B/E move
- 2.0%
45Δ
- Pseudo strike
- 1417.89
- IV
- 40.6%
- B/E move
- 1.8%
- Pseudo strike
- 1404.44
- IV
- 43.9%
- B/E move
- 1.8%
50Δ
- Pseudo strike
- 1411.28
- IV
- 40.2%
- B/E move
- 1.5%
- Pseudo strike
- 1411.30
- IV
- 41.4%
- B/E move
- 1.4%
55Δ
- Pseudo strike
- 1405.29
- IV
- 36.5%
- B/E move
- 1.2%
- Pseudo strike
- 1418.22
- IV
- 41.9%
- B/E move
- 1.2%
60Δ
- Pseudo strike
- 1398.10
- IV
- 41.2%
- B/E move
- 1.1%
- Pseudo strike
- 1425.85
- IV
- 44.2%
- B/E move
- 1.1%
65Δ
- Pseudo strike
- 1392.14
- IV
- 39.1%
- B/E move
- 0.9%
- Pseudo strike
- 1431.92
- IV
- 41.5%
- B/E move
- 0.8%
70Δ
- Pseudo strike
- 1385.00
- IV
- 39.5%
- B/E move
- 0.7%
- Pseudo strike
- 1441.95
- IV
- 44.8%
- B/E move
- 0.7%
75Δ
- Pseudo strike
- 1378.68
- IV
- 38.2%
- B/E move
- 0.6%
- Pseudo strike
- 1453.26
- IV
- 47.5%
- B/E move
- 0.6%
80Δ
- Pseudo strike
- 1369.49
- IV
- 39.4%
- B/E move
- 0.4%
- Pseudo strike
- 1466.43
- IV
- 49.8%
- B/E move
- 0.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 40.39% | |
| 39.25% | |
| 31.43% | |
| 33.28% | |
| 32.79% | |
| 31.77% | |
| 31.56% | |
| 28.42% | |
| 31.68% | |
| 32.22% | |
| 32.97% | |
| 31.62% | |
| 30.79% | |
| 32.05% | |
| 32.81% | |
| 33.52% | |
| 32.18% | |
| 29.94% | |
| 31.47% | |
| 31.92% | |
| 31.63% | |
| 31.10% | |
| 30.11% | |
| 34.53% | |
| 33.13% | |
| 33.38% | |
| 30.65% | |
| 32.63% | |
| 33.84% | |
| 33.96% | |
| 32.53% | |
| 30.52% | |
| 32.75% | |
| 32.24% | |
| 32.32% | |
| 32.87% | |
| 31.28% | |
| 33.68% | |
| 33.14% | |
| 33.87% | |
| 32.41% | |
| 32.51% | |
| 34.67% | |
| 35.55% | |
| 35.75% | |
| 36.26% | |
| 36.61% | |
| 39.33% | |
| 40.42% | |
| 42.16% | |
| 41.14% | |
| 42.35% | |
| 44.09% | |
| 45.80% | |
| 45.67% | |
| 47.45% | |
| 47.95% | |
| 54.27% | |
| 58.61% | |
| 62.46% | |
| 37.43% | |
| 34.19% |
Drug Manufacturers - General
MRK
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in…
More →NVO
Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in…
More →NVS
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
More →OGN
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine,…
More →PFE
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company…
More →SNY
Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The…
More →